The Effect of Pancreatic Polypeptide on Insulin Requirements for Type 1 & Post-pancreatectomy Diabetic Patients

NCT00791076 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

8

Enrollment

OTHER

Sponsor class

Stopped PI left JHU

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG: Placebo
DRUG: Pancreatic Polypeptide (PP)

Sponsor

Johns Hopkins University